PRITHVIRAJ BOSE to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications PRITHVIRAJ BOSE has written about Xenograft Model Antitumor Assays.
Connection Strength
0.127
-
Developmental Therapeutics in Myeloproliferative Neoplasms. Clin Lymphoma Myeloma Leuk. 2017 07; 17S:S43-S52.
Score: 0.082
-
Superior efficacy of cotreatment with BET protein inhibitor and BCL2 or MCL1 inhibitor against AML blast progenitor cells. Blood Cancer J. 2019 01 15; 9(2):4.
Score: 0.023
-
Targeting nuclear ?-catenin as therapy for post-myeloproliferative neoplasm secondary AML. Leukemia. 2019 06; 33(6):1373-1386.
Score: 0.023